Introduction
Conjugated bile acids, free fatty acids, and nonbile acid cholephils including sulfobromophthalein (BSP)' and bilirubin represent three classes of organic anions efficiently extracted from blood by the liver (1) despite tight binding to albumin (2) (3) (4) . Hepatocellular uptake processes for these three classes of organic anions share common features. Each exhibits a series of kinetic phenomena that have come to be called the albumin receptor effect (5) (6) (7) (8) ; for each, a specific liver plasma membrane (LPM) binding protein (9) (10) (11) (12) and a discrete cytosolic receptor protein (13) (14) (15) have been identified. The hepatocellular uptake kinetics ofbile acids (16) (17) , free fatty acids (18) , and BSP and bilirubin (19) (20) are all compatible with carrier-mediated transport, and the bile acid transport system has been partially reconstituted in artificial liposomes by incorporation of the LPM bile acid binding protein into synthetic lipid bilayers (21) . A physiologic role for the LPM fatty acid binding protein has recently been established in studies showing that antibodies to this protein selectively inhibit hepatocellular fatty acid uptake (18) . An analogous transport function for the LPM-BSP/bilirubin binding protein has been postulated (9, 22) but not yet established.
In the present study we demonstrate that a rabbit antibody to the rat LPM-BSP/bilirubin binding protein selectively inhibits Berry and Friend (23) previously described in detail (18) . The resulting homogenous single cell suspension was washed twice by addition of 0.15 M NaCl/ 0.02 M phosphate buffer (PBS) (pH 7.4) and centrifugation at 50 g for 1.5 min. After dilution to a concentration of 2 X 106 cells/ml with PBS, the hepatocyte suspension was stored on ice for up to 2 h until use. Viability tests were routinely done on every preparation before and after each experiment, and included trypan blue exclusion and determinations of lactate dehydrogenase leakage, intracellular K+ concentration, and stimulation of respiration by succinate (18) .
Uptake studies. 7 .0±0.7 AM) was significantly increased (P < 0.0001), indicating purely competitive inhibition of BSP uptake by bilirubin. These results are compatible with the hypothesis that BSP and bilirubin share a common uptake mechanism, which is distinct from the uptake mechanism of the other classes of organic anions tested.
Effects ofion substitution and inhibitors. Substitution of 110 mM KCI/25 mM NaCl, 143 mM LiCl, or 246 mM sucrose for 143 mM NaCl in the incubation medium had no effect on Vo Antibody Inhibition ofSulfobromophthalein and Bilirubin Uptake 823 anti-LPM-BSP/bilirubin binding protein, when compared to controls pretreated with preimmune serum (Fig. 3) remained >90% at the end of these studies, and no increased leakage of LDH into the medium was observed, indicating lack of hepatocellular toxicity from the antibody employed.
Discussion
The hepatocellular uptake of conjugated bile acids, free fatty acids and non-bile acid cholephils such as BSP and bilirubin, representing the three major physiologic classes of albuminbound organic anions in plasma, now appears to occur by distinct BSP INCUBATED (MM) but had no effect on the nonspecific uptake component measured at 4VC. Consequently, specific uptake, representing the difference between the curves measured at 370C and 4VC was also significantly inhibited.
but highly analogous class-specific, membrane-associated transport processes (1). Historically, for each class, the kinetics of hepatocellular uptake were shown to be compatible with carriermediated transport (16) (17) (18) (19) (20) ; high affinity class-specific binding sites were demonstrated on isolated liver plasma membranes (11, [29] [30] [31] ; and a specific membrane binding protein or proteins was isolated and characterized (9) (10) (11) (12) (10) , designated organic anion binding protein (OABP), appears closely related to the protein initially reported from our laboratory (9, 22) , on the basis of similarities of subunit molecular weight, sialic acid content, ligand specificity (9) , and at least partial immunologic crossreactivity (32) . The relation if any, ofthese proteins to the "bilitranslocase" reported by Tiribelli and associates (33) remains to be established. The most recently reported subunit structure and molecular weight estimates (34) suggest, that they are in fact unrelated. The reported inhibition ofBSP transport in the isolated perfused rat liver by an antibody to bilitranslocase (35) lacked evidence of specificity and any investigation of antibody toxicity, which we have found to be a significant problem with some antibody preparations in studies of this type.
One technical issue requires comment. The current studies are done in the absence of albumin, which ordinarily serves as the physiologic carrier for the anions studied. This decision was made in order to avoid obscuring the fundamental transport kinetics ofthe cellular uptake mechanism with the complexities ofligand-albumin binding and ofthe so-called albumin receptor effect (5) (6) (7) (8) (36) (37) (38) . Recent analyses suggest that binding phenomena may so greatly modify uptake kinetics as to render interpretation of such studies problematical (39) . The absence of albumin may have modified some of the quantitative transport variables measured in our study. Nevertheless, this should in no way alter the straightforward interpretation of the role of anti-LPM-BSP/bilirubin binding protein.
A complete understanding of a transport process requires not only recognition of the molecular machinery involved, but also of the driving forces. In this regard, knowledge of BSP and bilirubin uptake lags behind that of bile acids and free fatty acids, both of which are sodium-linked, energy-dependent processes (16) (17) (18) . BSP uptake does not appear to be sodium coupled or to require directly cellular energy in the form of ATP (40) . Recent preliminary studies in vesicles (41) and hepatocytes (42) suggest some relationship of BSP uptake to that of chloride by an as yet unexplained mechanism. Determination ofthe driving forces for BSP and bilirubin uptake appears to be the next major challenge in the thorough understanding ofthis transport process.
